We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results:1-3 of 3

Venture capital goes to Capitol Hill to decrease regulatory burdens on medical device industry
  • Shook Hardy & Bacon LLP
  • USA
  • November 3 2011

According to a recent New York Times business article, venture capital funds are contributing to the campaigns of politicians calling for streamlined Food and Drug Administration (FDA) medical device approval procedures and increasing their lobbying presence in Washington, D.C.


T2 Biosystems completes $23-million series D financing for diagnostic technology
  • Shook Hardy & Bacon LLP
  • USA
  • August 18 2011

T2 Biosystems has closed a $23-million series D financing to support progress toward regulatory approval for its T2MR medical diagnostic technology, designed to rapidly detect Candida, a fungal pathogen known to cause blood-stream infections and sepsis.


Financial group analyzes M&A deals in biotech and medical device industries
  • Shook Hardy & Bacon LLP
  • USA
  • June 16 2011

According to an SVP Financial Group report, contrary to conventional wisdom, biotech exits occur faster than device exits and have lower, but solid, multiples on invested capital.